These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1363715)

  • 1. Topochemical design of bioactive peptides and peptidomimetics.
    Goodman M; Ro S; Yamazaki T; Spencer JR; Toy A; Huang Z; He Y; Reisine T
    Bioorg Khim; 1992; 18(10-11):1375-93. PubMed ID: 1363715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly potent side chain-main chain cyclized dermorphin-deltorphin analogues: an integrated approach including synthesis, bioassays, NMR spectroscopy and molecular modelling.
    Ro S; Zhu Q; Lee CW; Goodman M; Darlak K; Spatola AF; Chung NN; Schiller PW; Malmberg AB; Yaksh TL
    J Pept Sci; 1995; 1(3):157-74. PubMed ID: 9222993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic hexapeptide analogs of somatostatin containing bridge modifications. Syntheses and conformational analyses.
    Huang Z; Pröbstl A; Spencer JR; Yamazaki T; Goodman M
    Int J Pept Protein Res; 1993 Oct; 42(4):352-65. PubMed ID: 7902342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational analyses of cyclic hexapeptide analogs of somatostatin containing arylalkyl peptoid and naphthylalanine residues.
    Mattern RH; Tran TA; Goodman M
    J Pept Sci; 1999 Apr; 5(4):161-75. PubMed ID: 10323196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absolute configuration for peptidomimetic residues in bioactive peptides.
    Yamazaki T; Goodman M
    Chirality; 1991; 3(4):268-76. PubMed ID: 1742164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic hexapeptides related to somatostatin. Synthesis and biological testing.
    Pattaroni C; Lucietto P; Goodman M; Yamamoto G; Vale W; Moroder L; Gazerro L; Göhring W; Schmied B; Wünsch E
    Int J Pept Protein Res; 1990 Nov; 36(5):401-17. PubMed ID: 1980489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular basis of opioid potency and selectivity: morphiceptins, dermorphins, deltorphins, and enkephalins.
    Goodman M; Ro S; Osapay G; Yamazaki T; Polinsky A
    NIDA Res Monogr; 1993; 134():195-209. PubMed ID: 7904724
    [No Abstract]   [Full Text] [Related]  

  • 8. Conformational analyses by 1H NMR and computer simulations of cyclic hexapeptides related to somatostatin containing acidic and basic peptoid residues.
    Mattern RH; Tran TA; Goodman M
    J Pept Res; 1999 Feb; 53(2):146-60. PubMed ID: 10195452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biologic activity of conformationally constrained analogs of L-363,301.
    Moore SB; Grant M; Rew Y; Bosa E; Fabbri M; Kumar U; Goodman M
    J Pept Res; 2005 Dec; 66(6):404-22. PubMed ID: 16316457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced peptide bond cyclic somatostatin based opioid octapeptides. Synthesis, conformational properties and pharmacological characterization.
    Kazmierski WM; Ferguson RD; Knapp RJ; Lui GK; Yamamura HI; Hruby VJ
    Int J Pept Protein Res; 1992 May; 39(5):401-14. PubMed ID: 1358847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights on mu/delta selectivity of opioid peptides: conformational analysis of deltorphin analogues.
    Tancredi T; Temussi PA; Picone D; Amodeo P; Tomatis R; Salvadori S; Marastoni M; Santagada V; Balboni G
    Biopolymers; 1991 May; 31(6):751-60. PubMed ID: 1932571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational and topographical considerations in the design of biologically active peptides.
    Hruby VJ
    Biopolymers; 1993 Jul; 33(7):1073-82. PubMed ID: 8102072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid peptides. Partially modified retro-inverso dermorphin analogues. XIII.
    Marastoni M; Balboni G; Tomatis R; Salvadori S; Borea PA; Uccelli L
    Farmaco; 1989 Nov; 44(11):1083-93. PubMed ID: 2562001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 14-membered cyclic opioids related to dermorphin and their partially retro-inverso modified analogues. II. Preferred conformations in solution as studied by 1H-NMR spectroscopy.
    Yamazaki T; Mierke DF; Said-Nejad OE; Felder ER; Goodman M
    Int J Pept Protein Res; 1992 Feb; 39(2):161-81. PubMed ID: 1517015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and biological activities of potent and selective somatostatin analogues incorporating novel peptoid residues.
    Tran TA; Mattern RH; Afargan M; Amitay O; Ziv O; Morgan BA; Taylor JE; Hoyer D; Goodman M
    J Med Chem; 1998 Jul; 41(15):2679-85. PubMed ID: 9667958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent developments in retro peptides and proteins--an ongoing topochemical exploration.
    Chorev M; Goodman M
    Trends Biotechnol; 1995 Oct; 13(10):438-45. PubMed ID: 7546569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and binding properties of cyclohexapeptide somatostatin analogs containing naphthylalanine and arylalkyl peptoid residues.
    Tran TA; Mattern RH; Morgan BA; Taylor JE; Goodman M
    J Pept Sci; 1999 Mar; 5(3):113-30. PubMed ID: 10323556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic retro-inverso dipeptides with two aromatic side chains. II. Conformational analysis.
    Yamazaki T; Nunami K; Goodman M
    Biopolymers; 1991 Nov; 31(13):1513-28. PubMed ID: 1814501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dermenkephalin (Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2): a potent and fully specific agonist for the delta opioid receptor.
    Amiche M; Sagan S; Mor A; Delfour A; Nicolas P
    Mol Pharmacol; 1989 Jun; 35(6):774-9. PubMed ID: 2543911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endomorphins: potential roles and therapeutic indications in the development of opioid peptide analgesic drugs.
    Liu WX; Wang R
    Med Res Rev; 2012 May; 32(3):536-80. PubMed ID: 21287571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.